Published in J Pathol on February 01, 1999
Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol (2004) 1.82
The psoriatic transcriptome closely resembles that induced by interleukin-1 in cultured keratinocytes: dominance of innate immune responses in psoriasis. Am J Pathol (2007) 1.29
Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol (2004) 1.08
Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest (2009) 1.03
A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin. J Invest Dermatol (2012) 1.00
Facilitated wound healing by activation of the Transglutaminase 1 gene. Am J Pathol (2000) 0.91
Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res (2014) 0.80
[Testosterone reduces the expression of keratinization-promoting genes in murine Meibomian glands]. Ophthalmologe (2013) 0.76
Interleukin-1 Gene Polymorphisms and their Relation with NFκB Expression and Histopathological Features in Psoriasis. Indian J Dermatol (2015) 0.75
Production of refractory dissolved organic matter by bacteria. Science (2001) 2.72
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Bulk chemical characteristics of dissolved organic matter in the ocean. Science (1992) 2.31
Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. J Am Acad Dermatol (1995) 2.14
Antibody formation in mouse bone marrow. I. Evidence for the development of plaque-forming cells in situ. Immunology (1974) 1.65
Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol (2012) 1.58
A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J Exp Med (2001) 1.48
Regulated genes in psoriatic skin during treatment with fumaric acid esters. Br J Dermatol (2014) 1.45
Antibody formation in mouse bone marrow. IV. The influence of splenectomy on the bone marrow plaque-forming cell response to sheep red blood cells. Cell Immunol (1975) 1.42
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis (2006) 1.41
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy (1996) 1.41
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol (2015) 1.39
Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers. Antimicrob Agents Chemother (1990) 1.37
The mechanism of thymus-dependent antibody formation in bone marrow. J Immunol (1981) 1.37
Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered "antigen-free" diet. Eur J Immunol (1984) 1.37
Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in germ-free BALB/c mice fed chemically defined ultrafiltered diet. Eur J Immunol (1989) 1.32
Degradation of polysaccharides and lignin by ruminal bacteria and fungi. Appl Environ Microbiol (1988) 1.22
Clones of helper T cells mediate antigen-specific, H-2-restricted DTH. Nature (1981) 1.21
Antibody formation in mouse bone marrow. IX. Peripheral lymphoid organs are involved in the initiation of bone marrow antibody formation. Cell Immunol (1977) 1.20
Cytokine networking in lungs of immunocompetent mice in response to inhaled Aspergillus fumigatus. Infect Immun (2001) 1.17
Isolation and quantification of dissolved lignin from natural waters using solid-phase extraction and GC/MS. Anal Chem (2000) 1.17
Pathogenesis and pharmacotherapy of Hidradenitis suppurativa. Eur J Pharmacol (2011) 1.14
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol (2009) 1.14
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol (2011) 1.14
Antibody formation in mouse bone marrow. III. Effects of route of priming and antigen dose. Immunology (1974) 1.12
Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. J Immunol (1985) 1.11
Antibody formation in mouse bone marrow. II. Evidence for a memory-dependent phenomenon. Cell Immunol (1974) 1.10
Improvement of the protein A plaque assay for immunoglobulin secreting cells by using immunoglobulin-depleted guinea pig serum as a source of complement. J Immunol Methods (1981) 1.08
The influence of exogenous antigenic stimulation on the specificity repertoire of background immunoglobulin-secreting cells of different isotypes. Cell Immunol (1988) 1.07
Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol (1990) 1.06
Cells involved in the graft-versus-host reaction in vitro. Immunology (1973) 1.06
The distribution of cytoplasmic immunoglobulin containing cells over various lymphoid organs of congenitally athymic (nude) mice as a function of age. Immunology (1979) 1.05
A "trans" perspective on the control of immunoglobulin c gene expression. Immunol Rev (1982) 1.05
Frequencies of background immunoglobulin-secreting cells in mice as a function if organ, age, and immune status. Immunobiology (1981) 1.03
Increased frequency of homogeneous immunoglobulins in the sera of nude athymic mice with age. Clin Immunol Immunopathol (1980) 1.02
Isolation of a bacterium capable of degrading peanut hull lignin. Appl Environ Microbiol (1983) 0.98
Characterization of an Lyt-2+ alloreactive cytotoxic T cell clone specific for H-2Db that cross-reacts with I-Ek. J Immunol (1986) 0.98
Serum immunoglobulins in nude mice and their heterozygous littermates during ageing. Immunology (1980) 0.97
Immunoglobulin isotype expression. II. Frequency analysis in mitogen-reactive B cells. Eur J Immunol (1981) 0.96
Regulation of the "spontaneous' (background) immunoglobulin synthesis. Int Arch Allergy Appl Immunol (1981) 0.96
Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infection. Infect Immun (2000) 0.95
Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha. Gene Ther (2005) 0.95
The effect of corticosteroids upon murine B cells in vivo and in vitro as determined in the LPS-culture system. Immunology (1987) 0.94
Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J Pathol (1996) 0.93
Increase of precursor frequency and clonal size of murine IgE-secreting cells by IL-4. J Immunol (1988) 0.93
Amplification of the c-myc and the pvt-like region in human multiple myeloma. Oncogene (1990) 0.91
The capacity and mechanism of bone marrow antibody formation by thymus-independent antigens. J Immunol (1982) 0.91
The recovery of the B cell compartment in lethally irradiated and reconstituted mice. Adv Exp Med Biol (1976) 0.91
Hyperthyroid myopathy and the response to treatment. Thyroid (1991) 0.90
The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol (1997) 0.90
A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes. Gene Ther (2001) 0.90
Early development of Ig-secreting cells in young of germ-free BALB/c mice fed a chemically defined ultrafiltered diet. Cell Immunol (1987) 0.90
Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects. Eur J Immunol (1995) 0.90
Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression. Hum Gene Ther (2005) 0.90
Inflammatory properties of peptidoglycan are decreased after degradation by human N-acetylmuramyl-L-alanine amidase. Eur Cytokine Netw (1997) 0.90
Determination of amino sugars in environmental samples with high salt content by high-performance anion-exchange chromatography and pulsed amperometric detection. Anal Chem (2000) 0.90
Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic and euthymic mice as a function of age and immune status. Immunology (1984) 0.90
Mobilization of B and T lymphocytes and haemopoietic stem cells by polymethacrylic acid and dextran sulphate. Cell Tissue Kinet (1977) 0.89
Regulation of delayed type hypersensitivity to host histocompatibility antigens during graft-versus-host reactions. Immunol Rev (1985) 0.89
B lymphocyte differentiation in lethally irradiated and reconstituted mice. I. The effect of Strontium-89 induced bone marrow aplasia on the recovery of the B cell compartment in the spleen. Cell Immunol (1976) 0.88
Flare-up of delayed-type hypersensitivity initially induced by murine cloned helper T cells. Cell Immunol (1987) 0.88
Retronectin-assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield. Cytotherapy (2008) 0.88
Corticosteroids and the humoral immune response of mice. II. Enhancement of bone marrow antibody formation to lipopolysaccharide by high doses of corticosteroids. Cell Immunol (1979) 0.87
Enhanced production of biologically active interleukin-1 alpha and interleukin-1 beta by psoriatic epidermal cells ex vivo: evidence of increased cytosolic interleukin-1 beta levels and facilitated interleukin-1 release. Eur J Immunol (1995) 0.87
B-Lymphocyte differentiation in lethally irradiated and reconstituted mice. II. Recovery of humoral immune responsiveness. Cell Immunol (1977) 0.87
Corticosteroids and the humoral immune response of mice i. Differential effect of corticosteroids upon antibody formation to sheep red blood cells in spleen and bone marrow. Cell Immunol (1978) 0.87
Complement split product C5a mediates the lipopolysaccharide-induced mobilization of CFU-s and haemopoietic progenitor cells, but not the mobilization induced by proteolytic enzymes. Cell Tissue Kinet (1986) 0.86
Human chorionic gonadotropin treatment of anti-Hu-associated paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry (2010) 0.86
CD1a+ and CD1a- accessory cells from human bronchoalveolar lavage differ in allostimulatory potential and cytokine production. Am J Respir Cell Mol Biol (1996) 0.86
Deficient antibody formation in the bone marrow of nude mice. Immunology (1978) 0.85
Idiopathic paraproteinaemia V. Expression of Igh1 and Igh5 allotypes within the homogeneous immunoglobulins of ageing (C57BL/LiARij X CBA/BrARij)F1 mouse. Clin Exp Immunol (1985) 0.85
Frequencies of background cytoplasmic Ig-containing cells in various lymphoid organs of athymic asplenic (lasat), athymic, asplenic and normal BALB/c mice. Immunology (1981) 0.85
The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease. Br J Dermatol (2014) 0.85
Kinetics of recovery of serum Ig levels and of cytoplasmic Ig positive cells in various lymphoid organs of nude mice after thymus transplantation. Immunology (1980) 0.85
Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol (1992) 0.84
A modified ex vivo skin organ culture system for functional studies. Arch Dermatol Res (2001) 0.84
Lipopolysaccharide-induced suppression of DTH-reactivity to histocompatibility antigens. I. Kinetic aspects and specificity. Immunobiology (1988) 0.84
Aging of the lymphoid system at the organ level. With special reference to the bone marrow as site of antibody production. Dev Comp Immunol (1980) 0.84
Graft-vs.-host reactions: mechanisms and contemporary theories. Crit Rev Clin Lab Sci (1985) 0.84
B cell repertoire in adult antigen-free and conventional neonatal BALB/c mice. II. Analysis of antigen-binding capacities in relation to VH gene usage. Eur J Immunol (1989) 0.84
The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells. J Invest Dermatol (1991) 0.84
Phoenix-ampho outperforms PG13 as retroviral packaging cells to transduce human T cells with tumor-specific receptors: implications for clinical immunogene therapy of cancer. Cancer Gene Ther (2006) 0.84
Functional aspects of helper T cell clones. Immunobiology (1982) 0.83
Secondary delayed-type hypersensitivity to sheep red blood cells in mice: a long-lived memory phenomenon. Cell Immunol (1977) 0.83
Antibody formation in mouse bone marrow. V. The response to the thymus-independent antigen Ecsherichia coli lipopolysaccharide. Immunology (1976) 0.83
Serum and secretory immunoglobulin levels in preleukaemic AKR mice and three other mouse strains. Adv Exp Med Biol (1979) 0.82
Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report. Dermatology (2013) 0.82
Interleukin 4 receptors on human bronchial epithelial cells. An in vivo and in vitro analysis of expression and function. Cytokine (1998) 0.82
Retroviral vectors for clinical immunogene therapy are stable for up to 9 years. Cancer Gene Ther (2008) 0.82
T-lymphocyte subpopulations in patients with various courses after hepatitis B virus infection. Scand J Gastroenterol (1984) 0.82
Characterization and origin of dissolved organic carbon in Yegua ground water in Brazos County, Texas. Ground Water (2001) 0.82
B lymphocyte differentiation in lethally irradiated and reconstituted mice. A histological study using immunofluorescent detection of B lymphocytes. Cell Tissue Res (1978) 0.82
Influence of 2'-deoxyguanosine upon the development of DTH effector T cells and suppressor T cells in vivo. J Immunol (1984) 0.81
Expression of cytokines and their receptors by psoriatic fibroblast. I. Altered IL-6 synthesis. Cytokine (1996) 0.81
Suppression of antigraft immunity by preimmunization. III. Characterization of suppressor T cells involved in suppression of the efferent phase of DTH against alloantigens. J Immunol (1986) 0.81
Nerve outgrowth and neuropeptide expression during the remodeling of human burn wound scars. A 7-month follow-up study of 22 patients. Burns (2001) 0.80